膝神经射频消融结局相关临床与技术因素:多中心分析
该多中心回顾性研究评估了265例接受膝神经射频消融(RFA)的膝痛患者,分析23项人口学、临床和技术变量与结局的关系。总体有效率为61.1%(95%CI 55.2%至67.0%)。多因素分析显示肥胖、未使用阿片类药物、无抑郁、使用冷却RFA及每个神经靶点多次消融与阳性结局相关。
要点
- 膝神经RFA总体有效率为61.1%,临床选择患者需考虑多种因素。
- 肥胖、未用阿片类药物、无抑郁与阳性结局独立相关。
- 使用冷却RFA及每个靶点多次消融与更高阳性结局相关。
核心结论
- 多种临床和技术因素与膝神经RFA治疗结局相关,应在患者选择和临床试验设计中考虑。
研究设计与样本
- 回顾性多中心分析,纳入265例因膝痛接受膝神经RFA的患者,评估23项人口学、临床和技术变量对结局的影响。
- 主要结局定义为平均膝痛评分下降>30%并持续至少3个月且无协同干预。
主要发现
- 总体阳性反应率为61.1%(95%CI 55.2%至67.0%)。
- 单变量分析中,较大电极尺寸(p=0.01)、重复消融(p=0.02)、预后阻滞期间疼痛缓解>80%(p=0.02)、未使用阿片类药物(p=0.04)、无共存精神疾病(p=0.02)、较低基线疼痛评分(p=0.01)及靶向>3根神经(p=0.02)与阳性结局相关。
- 多变量logistic分析中,肥胖(OR 3.68,95%CI 1.66至8.19,p=0.001)、未使用阿片类药物(OR 0.35,95%CI 0.16至0.77,p=0.009)、无抑郁(OR 0.29,95%CI 0.10至0.82,p=0.02)、使用冷却RFA(OR 3.88,95%CI 1.63至9.23,p=0.002)及每个神经靶点多次消融(OR 15.88,95%CI 4.24至59.50,p<0.001)与阳性结局相关。
临床怎么用
- 选择膝神经RFA患者时,应评估肥胖、阿片类药物使用、抑郁状态及预后阻滞反应。
- 技术操作上可考虑使用冷却RFA及每个神经靶点进行多次消融以提高成功率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There has been a surge in interest in radiofrequency ablation (RFA) of the genicular nerves over the past decade, with wide variability in selection, technique and outcomes. The aim of this study is to determine factors associated with treatment outcome. METHODS: We retrospectively evaluated the effect of 23 demographic, clinical and technical variables on outcomes in 265 patients who underwent genicular nerve RFA for knee pain at 2 civilian and 1 military hospital. A primary outcome was designated as a > 30% decrease in average knee pain score lasting at least 3 months without cointerventions. RESULTS: The overall rate of a positive response was 61.1% (95% CI 55.2% to 67.0%). In univariable analysis, larger electrode size (p=0.01), repeated lesions (p=0.02), having>80% pain relief during the prognostic block (p=0.02), not being on opioids (p=0.04), having no coexisting psychiatric condition (p=0.02), having a lower baseline pain score (p=0.01) and having >3 nerves targeted (p=0.02) were associated with a positive outcome. In multivariate logistic analysis, being obese (OR 3.68, 95% CI 1.66 to 8.19, p=0.001), not using opioids (OR 0.35, 95% CI 0.16 to 0.77, p=0.009), not being depressed (OR 0.29, 95% CI 0.10 to 0.82, p=0.02), use of cooled RFA (OR 3.88, 95% CI 1.63 to 9.23, p=0.002) and performing multiple lesions at each neural target (OR 15.88, 95% CI 4.24 to 59.50, p<0.001) were associated with positive outcome. CONCLUSIONS: We identified multiple clinical and technical factors associated with treatment outcome, which should be considered when selecting patients for RFA treatment and in the design of clinical trials.
引用
- Chen Y, Vu TH, Chinchilli VM, et al. Clinical and technical factors associated with knee radiofrequency ablation outcomes: a multicenter analysis. Reg Anesth Pain Med. 2021. PMID: 33558282. doi:10.1136/rapm-2020-102017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。